U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Long-term Nabilone Use: A Review of the Clinical Effectiveness and Safety [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Oct 16.

Cover of Long-term Nabilone Use: A Review of the Clinical Effectiveness and Safety

Long-term Nabilone Use: A Review of the Clinical Effectiveness and Safety [Internet].

Show details


Based on evidence from one systematic review and four small RCTs, nabilone appeared to be safe and efficacious for the treatment of PTSD-associated nightmares, and for pain and spasticity for up to nine weeks of treatment. However, evidence of safety and efficacy beyond nine weeks is currently lacking. Patients with PTSD reported improvements in distressing nightmares and well-being while undergoing treatment with nabilone relative to treatment with placebo.10 Improvements in pain and quality of life were also observed in other conditions.7,11,12 While adverse effects were common, they were not categorized as serious and were frequently related to the central nervous system. However, study authors noted that larger trials of longer duration were needed to replicate or confirm the results, given the limited durations of active treatment and limited numbers of included participants. No literature was identified that compared long-term and short-term use of nabilone in PTSD or other chronic conditions. As such, the durability of treatment efficacy remains uncertain and it is unclear if some adverse effects may improve over time with extended treatment.

Copyright © 2015 Canadian Agency for Drugs and Technologies in Health.

Copyright: This report contains CADTH copyright material and may contain material in which a third party owns copyright. This report may be used for the purposes of research or private study only. It may not be copied, posted on a web site, redistributed by email or stored on an electronic system without the prior written permission of CADTH or applicable copyright owner.

Links: This report may contain links to other information available on the websites of third parties on the Internet. CADTH does not have control over the content of such sites. Use of third party sites is governed by the owners’ own terms and conditions.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK326833


  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (522K)

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...